Literature DB >> 21688120

The expression of cyclin G in nasopharyngeal carcinoma and its significance.

Xing-Xing Ye1, Chi-Bo Liu, Jia-Yu Chen, Bao-Hong Tao, Cai Zhi-Yi.   

Abstract

To investigate the expression of cyclin G1, cyclin G2 in nasopharyngeal carcinoma (NPC) cell lines and its significance. The protein expression of cyclin G1, cyclin G2 in NPC cell lines of different differentiation degree (HNE2, CNE1) was detected by indirect immunofluorescence. The mRNA expression of cyclin G1, cyclin G2 in HNE2 and CNE1 was measured with RT-PCR. The cyclin G1 expression in HNE2 and CNE1 was weak, and cyclin G2 expression in the cytoplasm near cell membrane was strong, continuous, and homogeneous. The expression level of cyclin G1-mRNA in HNE2 was 2.097 ± 0.262, which was significantly higher than CNE1 (0.997 ± 0.286, P < 0.05); the expression level of cyclin G2-mRNA in HNE2 was 0.708 ± 0.107, which was significantly lower than CNE1 (1.216 ± 0.037, P < 0.05). Abnormal expression of cyclin G was closely related to tumor differentiation, the origin, and progression of NPC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21688120     DOI: 10.1007/s10238-011-0142-9

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  12 in total

Review 1.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

2.  Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression.

Authors:  M C Horne; G L Goolsby; K L Donaldson; D Tran; M Neubauer; A F Wahl
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

3.  Gene structure and chromosomal localization of mouse cyclin G2 (Ccng2).

Authors:  M R Jensen; T Audolfsson; C L Keck; D B Zimonjic; S S Thorgeirsson
Journal:  Gene       Date:  1999-04-16       Impact factor: 3.688

4.  Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro.

Authors:  Mao Ye; Ji-Kai Liu; Zhong-Xin Lu; Yan Zhao; Su-Fang Liu; Li-Li Li; Ming Tan; Xin-Xian Weng; Wei Li; Ya Cao
Journal:  FEBS Lett       Date:  2005-06-20       Impact factor: 4.124

5.  Specific induction of gadd45 in human melanocytes and melanoma cells after UVB irradiation.

Authors:  Rémy Pedeux; Karine Lefort; Cyrille Cuenin; Ulrich Cortes; Karine Kellner; Jean-François Doré; Hisayoshi Nakazawa
Journal:  Int J Cancer       Date:  2002-04-20       Impact factor: 7.396

6.  Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer.

Authors:  Evanthia Galanis; Stephanie K Carlson; Nathan R Foster; Val Lowe; Fernando Quevedo; Robert R McWilliams; Axel Grothey; Aminah Jatoi; Steven R Alberts; Joseph Rubin
Journal:  Mol Ther       Date:  2008-03-18       Impact factor: 11.454

7.  Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway.

Authors:  Mao Ye; Xiangjian Luo; Lili Li; Ying Shi; Ming Tan; Xinxian Weng; Wei Li; Jikai Liu; Ya Cao
Journal:  Cancer Lett       Date:  2007-12-18       Impact factor: 8.679

8.  Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.

Authors:  Lili Zhao; Tina Samuels; Sarah Winckler; Chandrashekhar Korgaonkar; Van Tompkins; Mary C Horne; Dawn E Quelle
Journal:  Mol Cancer Res       Date:  2003-01       Impact factor: 5.852

9.  Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead.

Authors:  Lorena Martínez-Gac; Miriam Marqués; Zaira García; Miguel R Campanero; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

Authors:  Francesca Fornari; Laura Gramantieri; Catia Giovannini; Angelo Veronese; Manuela Ferracin; Silvia Sabbioni; George Adrian Calin; Gian Luca Grazi; Carlo Maria Croce; Simona Tavolari; Pasquale Chieco; Massimo Negrini; Luigi Bolondi
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

View more
  10 in total

1.  The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.

Authors:  Lifei Jiang; Rong Liu; Yingying Wang; Chunmiao Li; Qinghua Xi; Jianxin Zhong; Jian Liu; Shuyun Yang; Juan Wang; Menghui Huang; Chunhui Tang; Zheng Fang
Journal:  J Mol Histol       Date:  2015-05-17       Impact factor: 2.611

2.  Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway.

Authors:  Ye Chen; Rui Yan; Bo Li; Jun Liu; Xiaoxia Liu; Wenyu Song; Chunling Zhu
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

3.  miR-23b suppresses lung carcinoma cell proliferation through CCNG1.

Authors:  Hongsheng Han; Zhenxian Zhang; Xueqin Yang; Wenfeng Yang; Chengwei Xue; Xiaoli Cao
Journal:  Oncol Lett       Date:  2018-07-20       Impact factor: 2.967

4.  Chronic cadmium exposure aggravates malignant phenotypes of nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway via hypermethylation of the casein kinase 1α promoter.

Authors:  Lin Peng; Yi-Teng Huang; Fan Zhang; Jiong-Yu Chen; Xia Huo
Journal:  Cancer Manag Res       Date:  2018-12-19       Impact factor: 3.989

5.  MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma.

Authors:  Chen Dai; Yan Zhang; Zhihua Xu; Mengxian Jin
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

6.  LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.

Authors:  Min Sun; Yanan Chen; Xiaobei Liu; Yajie Cui
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Effects of lncRNA ANRIL-knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells.

Authors:  Xueqian Hu; Ting Lou; Chunying Yuan; Yongsheng Wang; Xiaolong Tu; Yi Wang; Tingsu Zhang
Journal:  Oncol Lett       Date:  2021-06-28       Impact factor: 2.967

8.  Differential Molecular Stress Responses to Low Compared to High Doses of Ionizing Radiation in Normal Human Fibroblasts.

Authors:  Ilya O Velegzhaninov; Dmitry M Shadrin; Yana I Pylina; Anastasia V Ermakova; Olga A Shostal; Elena S Belykh; Anna V Kaneva; Olga V Ermakova; Dmitry Y Klokov
Journal:  Dose Response       Date:  2015-05-04       Impact factor: 2.658

9.  HRPDviewer: human ribosome profiling data viewer.

Authors:  Wei-Sheng Wu; Yu-Xuan Jiang; Jer-Wei Chang; Yu-Han Chu; Yi-Hao Chiu; Yi-Hong Tsao; Torbjörn E M Nordling; Yan-Yuan Tseng; Joseph T Tseng
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

10.  FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p-CCNG1 interaction network.

Authors:  Yan Tong Liu; Guo Qing Liu; Jing Min Huang
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.